Lindmik Pharmaceutical (Suzhou) Co., Ltd. (hereinafter referred to as Leming Pharmaceutical), which focuses on the research and production of transdermal drug delivery, and Guoyao Holdings Distribution Center Co., Ltd. (hereinafter referred to as Guokong Distribution), a subsidiary of Guoyao Holdings, the largest pharmaceutical distribution enterprise in China, jointly signed a strategic cooperation agreement. The two sides will conduct comprehensive cooperation and exploration in the fields of product hospital distribution and national commercial distribution (including e-commerce channels) in the future, Jointly committed to meeting the urgent clinical needs of patients with chronic skeletal muscle pain and osteoarthritis.

Mr. Kong Xuedong, Chairman and Party Secretary of Guokong Distribution Company, and Mr. Gu Danhui, Chairman of Leming Pharmaceutical, jointly witnessed the signing ceremony and delivered speeches. Mr. Ji Yongchang, Vice President of Leming Pharmaceutical, and Mr. Wang Shunyao, Vice General Manager of Sinopharm Holdings, signed a strategic cooperation framework agreement on behalf of both parties.

In his speech, Mr. Gu Danhui, chairman of Luming Pharmaceutical, said that Luming Pharmaceutical has always focused on the research and development and industrialization of transdermal drug delivery technology. At present, there are two non steroidal topical patches, flurbiprofen gel patch and loxoprofen sodium gel patch, which are reported for production and will soon enter the stage of commercialization, and will provide more effective clinical solutions for patients with chronic muscle pain and bone joints. Guokong Distribution has a nationally leading integrated drug distribution network and an efficient and efficient modern pharmaceutical logistics system, which can provide safe and efficient distribution and other value-added services for Leming Pharmaceutical's products. We look forward to more comprehensive cooperation between the two sides in the future.

Mr. Kong Xuedong, Chairman and Party Secretary of Guokong Distribution Company, stated that as a leading pharmaceutical distributor and supply chain service provider in China, Guoyao Holdings will provide in-depth services in channel establishment, supply chain system, and logistics resources for Leming Pharmaceutical's products after their launch. Relying on its well-established network layout, strong channel management capabilities, and professional marketing team and services, we complement each other's resources, empower each other, and grow and develop together with Leming Pharmaceutical. Both sides work together to benefit more Chinese patients with high-quality drugs with significant therapeutic effects, and jointly contribute to the development of China's health industry.

Lindmik Pharmaceutical (Suzhou) Co., Ltd. is a high-tech pharmaceutical enterprise that focuses on the research and development, production, and sales of innovative pharmaceutical formulations. The company adheres to the dual engine driven development strategy of independent research and international cooperation. The company has independent research and development platforms for various dosage forms in the field of transdermal drug delivery, and multiple transdermal products are about to enter the commercialization stage; Leming Pharmaceutical also continues to introduce cutting-edge pharmaceutical technologies such as nano drug delivery and microsphere drug delivery through international cooperation and development. Based on a deep understanding of the Chinese pharmaceutical market, Leming Pharmaceutical focuses on differentiated pharmaceutical innovation with a focus on addressing unmet clinical needs. It has a complete research and development, production, and sales system, and high growth potential.

China National Pharmaceutical Holdings Distribution Center Co., Ltd. is a directly affiliated enterprise with the central government. The company was registered and established in January 2003 in the China (Shanghai) Pilot Free Trade Zone with a registered capital of 2 billion RMB. The Distribution Center of Sinopharm Holdings is a wholly-owned subsidiary of Sinopharm Holdings Co., Ltd. It serves as a national operation and management platform for integrating national procurement resources and integrating procurement and sales. It undertakes the national import, procurement, and distribution tasks of most strategic varieties of Sinopharm Holdings. During the 13th Five Year Plan period, the company was recognized as the headquarters of a large enterprise in Pudong New Area by the Pudong New Area. In 2018, it was listed as one of the top 20 Shanghai goods import and export enterprises by the Shanghai Municipal Commission of Commerce. In 2021, it was awarded the "Shanghai International Trade Distribution Center Demonstration Enterprise" and has been awarded the Pudong New Area Economic Outstanding Contribution Award for seven consecutive years. Adhering to the corporate philosophy of "protecting life, caring for health" and fulfilling social mission, the company was awarded the Shanghai May Day Labor Award by the Shanghai Federation of Trade Unions.